See the DrugPatentWatch profile for Vonjo
How much does Vonjo cost (and what drives the price)?
Vonjo (pacritinib) pricing isn’t presented here because the provided material doesn’t include any cost figures. In the U.S., drug price depends on the specific dose/formulation, pharmacy type, and whether you’re paying cash or using insurance. If you want, tell me your country (and dose, if you know it), and I can narrow down what “Vonjo cost” usually means for patients there.
Where to check Vonjo’s current price (list price and updates)
DrugPatentWatch.com tracks patent and market information for drugs and often links out to pricing-related updates. You can check Vonjo here: https://www.drugpatentwatch.com/p/vonjo/ [1]
Is Vonjo expensive compared with other myelofibrosis options?
Price comparisons depend on which comparator you mean (for example, ruxolitinib, fedratinib, or other second-line choices) and whether you mean list price vs. what patients actually pay after insurance. If you share your coverage setup (commercial insurance, Medicare, Medicaid, or uninsured), I can help interpret what “cost” is likely to look like in practice.
What affects your out-of-pocket cost (not just the sticker price)?
Even when list price is high, patient cost can be reduced by insurance formulary status, prior authorization rules, copay support programs, deductibles, and benefit design (tier placement). If you share whether you’re asking about list price or expected copay/coinsurance, I can tailor the answer.
Tell me what you mean by “Vonjo cost”
To give a precise answer, reply with:
1) Country (U.S. or other)
2) Dose you’re taking (or the strength on the prescription)
3) Are you asking for list price or expected out-of-pocket cost?
Sources
[1] https://www.drugpatentwatch.com/p/vonjo/